SEARCH

SEARCH BY CITATION

References

  • 1
    Rerolle J-P, Hertig A, Nguyen G, Sraer J-D, Rondeau EP. Plasminogen activator inhibitor type 1 is a potential target in renal fibrogenesis. Kidney Int 2000; 58: 184150.
  • 2
    Chan JCY, Duszczyszyn DA, Castellino FJ, Ploplis VA. Accelerated skin wound healing in plasminogen activator inhibitor-1-deficient mice. Am J Pathol 2001; 159: 16818.
  • 3
    Hagood JS, Olman MA, Godoy JA, Rivera KE, Fuller GM. Regulation of type I plasminogen activator inhibitor by fibrin degradation products in rat lung fibroblasts. Blood 1996; 87: 374957.
  • 4
    Andrew A, Barchowsky A. Nickel-induced plasminogen activator inhibitor-1 expression inhibits the fibrinolytic activity of human airway epithelial cells. Toxicol Appl Pharmacol 2000; 168: 507.DOI: 10.1006/taap.2000.9009
  • 5
    Gardi C, Arezzini B, Fortino V, Comporti M. Effect of free iron on collagen synthesis, cell proliferation and MMP-2 expression in rat hepatic stellate cells. Biochem Pharmacol 2002; 64: 113945.DOI: 10.1016/S0006-2952(02)01257-1
  • 6
    Wenk J, Foitzik A, Achterberg V, Sabiwalsky A, Dissemond J, Meewes C, Reitz A, Brenneisen P, Wlaschek M, Meyer-Ingold W, Scharffetter-Kochanek K. Selective pick-up of increased iron by deferoxamine-coupled cellulose abrogates the iron-driven induction of matrix-degrading metalloproteinase 1 and lipid peroxidation in human dermal fibroblasts in vitro: a new dressing concept. J Invest Dermatol 2001; 116: 8339.DOI: 10.1046/j.1523-1747.2001.01345.x
  • 7
    Yoshida E, Ohmura S, Sugiki M, Anai K, Maruyama M. A novel function of extraerythrocytic hemoglobin: identification of globin as a stimulant of plasminogen activator biosynthesis in human fibroblasts. Thromb Haemost 2001; 86: 15217.
  • 8
    Mattia E, Den Blaauwen J, Ashwell G, Van Renswoude J. Multiple post-transcriptional regulatory mechanisms in ferritin gene expression. Proc Natl Acad Sci USA 1989; 86: 18015.
  • 9
    Tanji K, Imaizumi T, Matsumiya T, Itaya H, Fujimoto K, Cui X, Toki T, Ito E, Yoshida H, Wakabayashi K, Satoh K. Desferrioxamine, an iron chelator, upregulates cyclooxygenase-2 expression and prostaglandin production in a human macrophage cell line. Biochim Biophys Acta 2001; 1530: 22735.
  • 10
    Ye Z, Connor JR. Screening of transcriptionally regulated genes following iron chelation in human astrocytoma cells. Biochem Biophys Res Commun 1999; 264: 70913.DOI: 10.1006/bbrc.1999.1554
  • 11
    Beerepoot LV, Shima DT, Kuroki M, Yeo KT, Voest EE. Up-regulation of vascular endothelial growth factor production by iron chelators. Cancer Res 1996; 56: 374751.
  • 12
    Templeton DM, Liu Y. Genetic regulation of cell function in response to iron overload or chelation. Biochim Biophys Acta 2003; 1619: 11324.
  • 13
    Dignam JD, Martin PL, Shastry BS, Roeder RG. Eukaryotic gene transcription with purified components. Methods Enzymol 1983; 101: 58298.
  • 14
    Stephens RW, Pollanen J, Tapiovaara H, Leung KC, Sim PS, Salonen EM, Ronne E, Behrendt N, Dano K, Vaheri A. Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants. J Cell Biol 1989; 108: 198795.DOI: 10.1083/jcb.108.5.1987
  • 15
    Ryan MP, Kutz SM, Higgins PJ. Complex regulation of plasminogen activator inhibitor type-1 (PAI-1) gene expression by serum and substrate adhesion. Biochem J 1996; 314: 10416.
  • 16
    Arts J, Grimbergen J, Toet K, Kooistra T. On the role of c-Jun in the induction of PAI-1 gene expression by phorbol ester, serum, and IL-1{alpha} in HepG2 cells. Arterioscler Thromb Vasc Biol 1999; 19: 3946.
  • 17
    Rao K, Harford JB, Rouault T, McClelland A, Ruddle FH, Klausner RD. Transcriptional regulation by iron of the gene for the transferrin receptor. Mol Cell Biol 1986; 6: 23640.
  • 18
    Goto Y, Paterson M, Listowsky I. Iron uptake and regulation of ferritin synthesis by hepatoma cells in hormone-supplemented serum-free media. J Biol Chem 1983; 258: 524855.
  • 19
    Voest EE, Rooth H, Neijt JP, Van Asbeck BS, Marx JJ. The in vitro response of human tumour cells to desferrioxamine is growth medium dependent. Cell Prolif 1993; 26: 7788.
  • 20
    West MD, Shay JW, Wright WE, Linskens MH. Altered expression of plasminogen activator and plasminogen activator inhibitor during cellular senescence. Exp Gerontol 1996; 31: 17593.DOI: 10.1016/0531-5565(95)02013-6
  • 21
    Mu XC, Staiano-Coico L, Higgins PJ. Increased transcription and modified growth state-dependent expression of the plasminogen activator inhibitor type-1 gene characterize the senescent phenotype in human diploid fibroblasts. J Cell Physiol 1998; 174: 908.DOI: 10.1002/(SICI)1097-4652(199801)174:1<90::AID-JCP10>3.0.CO;2-S
  • 22
    Rouault TA. Post-transcriptional regulation of human iron metabolism by iron regulatory proteins. Blood Cells Mol Dis 2002; 29: 30914.DOI: 10.1006/bcmd.2002.0571
  • 23
    Pepper MS. Extracellular proteolysis and angiogenesis. Thromb Haemost 2001; 86: 34655.
  • 24
    Van Meijer M, Pannekoek H. Structure of plasminogen activator inhibitor 1 (PAI-1) and its function in fibrinolysis: an update. Fibrinolysis 1995; 9: 26376.
  • 25
    Irigoyen JP, Munoz-Canoves P, Montero L, Koziczak M, Nagamine Y. The plasminogen activator system: biology and regulation. Cell Mol Life Sci 1999; 56: 10432.
  • 26
    Heaton JH, Dlakic WM, Dlakic M, Gelehrter TD. Identification and cDNA cloning of a novel RNA-binding protein that interacts with the cyclic nucleotide-responsive sequence in the type-1 plasminogen activator inhibitor mRNA. J Biol Chem 2001; 276: 33417.DOI: 10.1074/jbc.M006538200
  • 27
    Shetty S, Bdeir K, Cines DB, Idell S. Induction of plasminogen activator inhibitor-1 by urokinase in lung epithelial cells. J Biol Chem 2003; 278: 1812431.DOI: 10.1074/jbc.M207445200
  • 28
    Sandler M, Zhang J, Westerhausen D Jr, Billadello J. A novel protein interacts with the major transforming growth factor- beta responsive element in the plasminogen activator inhibitor type-1 gene. J Biol Chem 1994; 69: 215004.
  • 29
    Hasegawa T, Sorensen L, Ooi H, Marshall BC. Decreased intracellular iron availability suppresses epithelial cell surface plasmin generation. Transcriptional and post-transcriptional effects on u-PA and PAI-1 expression. Am J Respir Cell Mol Biol 1999; 21: 27582.
  • 30
    Yeh LC, Mikhailov V, Lee JC. Regulation of expression of plasminogen activator inhibitor-1 in cultured rat osteoblastic cells by osteogenic protein-1 (BMP-7). J Cell Biochem 2001; 81: 4654.DOI: 10.1002/jcb.1071
  • 31
    Horton MR, Olman MA, Bao C, White KE, Choi AMK, Chin B-Y, Noble PW, Lowenstein CJ. Regulation of plasminogen activator inhibitor-1 and urokinase by hyaluronan fragments in mouse macrophages. Am J Physiol Lung Cell Mol Physiol 2000; 279: L70715.
  • 32
    Bosma PJ, Kooistra T. Different induction of two plasminogen activator inhibitor 1 mRNA species by phorbol ester in human hepatoma cells. J Biol Chem 1991; 266: 178459.
  • 33
    Fattal P, Schneider D, Sobel B, Billadello J. Post-transcriptional regulation of expression of plasminogen activator inhibitor type 1 mRNA by insulin and insulin-like growth factor 1. J Biol Chem 1992; 267: 124125.
  • 34
    Faa GCG. Iron chelating agents in clinical practice. Coordination Chem Rev 1999; 184: 291310.DOI: 10.1016/S0010-8545(99)00056-9
  • 35
    Cazzola M, Bergamaschi G, Dezza L, Arosio P. Manipulations of cellular iron metabolism for modulating normal and malignant cell proliferation: achievements and prospects. Blood 1990; 75: 190319.
  • 36
    Rothman RJ, Serroni A, Farber JL. Cellular pool of transient ferric iron, chelatable by deferoxamine and distinct from ferritin, that is involved in oxidative cell injury. Mol Pharmacol 1992; 42: 70310.
  • 37
    Fast B, Kremp K, Boshart M, Steverding D. Iron-dependent regulation of transferrin receptor expression in Trypanosoma brucei. Biochem J 1999; 342: 6916.DOI: 10.1042/0264-6021:3420691
  • 38
    Martelin E, Lapatto R, Raivio KO. Regulation of xanthine oxidoreductase by intracellular iron. Am J Physiol Cell Physiol 2002; 283: C17228.
  • 39
    Hoepken HH, Korten T, Robinson SR, Dringen R. Iron accumulation, iron-mediated toxicity and altered levels of ferritin and transferrin receptor in cultured astrocytes during incubation with ferric ammonium citrate. J Neurochem 2004; 88: 1194202.DOI: 10.1046/j.1471-4159.2003.02236.x
  • 40
    Yankulov K, Yamashita K, Roy R, Egly J-M, Bentley DL. The transcriptional elongation inhibitor 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole inhibits transcription factor IIH-associated protein kinase. J Biol Chem 1995; 270: 239225.DOI: 10.1074/jbc.270.41.23922
  • 41
    Posch M, Sutterluety H, Skern T, Seiser C. Characterization of the translation-dependent step during iron-regulated decay of transferrin receptor mRNA. J Biol Chem 1999; 274: 166118.DOI: 10.1074/jbc.274.23.16611
  • 42
    Mayer M, Lund LR, Riccio A, Skouv J, Nielsen LS, Stacey SN, Dano K, Andreasen PA. Plasminogen activator inhibitor type-1 protein, mRNA and gene transcription are increased by phorbol esters in human rhabdomyosarcoma cells. J Biol Chem 1988; 263: 1568893.
  • 43
    Van Den Berg EA, Sprengers ED, Jaye M, Burgess W, Maciag T, Van Hinsbergh VW. Regulation of plasminogen activator inhibitor-1 mRNA in human endothelial cells. Thromb Haemost 1988; 60: 637.
  • 44
    Shetty S, Idell S. Posttranscriptional regulation of plasminogen activator inhibitor-1 in human lung carcinoma cells in vitro. Am J Physiol Lung Cell Mol Physiol 2000; 278: L14856.
  • 45
    Koeller DM, Horowitz JA, Casey JL, Klausner RD, Harford JB. Translation and the stability of mRNAs encoding the transferrin receptor and c-fos. Proc Natl Acad Sci USA 1991; 88: 777882.
  • 46
    Ross J. mRNA stability in mammalian cells. Microbiol Rev 1995; 59: 42350.
  • 47
    Leibold EA, Munro HN. Cytoplasmic protein binds in vitro to a highly conserved sequence in the 5′ untranslated region of ferritin heavy- and light-subunit mRNAs. Proc Natl Acad Sci USA 1988; 85: 21715.
  • 48
    Shih SC, Claffey KP. Regulation of human vascular endothelial growth factor mRNA stability in hypoxia by heterogeneous nuclear ribonucleoprotein L. J Biol Chem 1999; 274: 135965.DOI: 10.1074/jbc.274.3.1359
  • 49
    Rajagopalan LE, Westmark CJ, Jarzembowsk JA, Malter JS. hnRNP C increases amyloid precursor protein (APP) production by stabilizing APP mRNA. Nucl Acids Res 1998; 26: 341823.DOI: 10.1093/nar/26.14.3418
  • 50
    Kiledjian M, DeMaria CT, Brewer G, Novick K. Identification of AUF1 (heterogeneous nuclear ribonucleoprotein D) as a component of the alpha-globin mRNA stability complex. Mol Cell Biol 1997; 17: 48706.
  • 51
    Zaidi SH, Malter JS. Nucleolin and heterogeneous nuclear ribonucleoprotein C proteins specifically interact with the 3′-untranslated region of amyloid protein precursor mRNA. J Biol Chem 1995; 270: 172928.DOI: 10.1074/jbc.270.29.17292
  • 52
    Shetty S. Cytoplasmic–nuclear shuttling of the urokinase mRNA binding protein regulates message stability. Mol Cell Biochem 2002; 237: 5567.DOI: 10.1023/A:1016558200199
  • 53
    Klausner RD, Harford JB. Cis-trans models for post-transcriptional gene regulation. Science 1989; 246: 8702.
  • 54
    Henderson BR, Menotti E, Kuhn LC. Iron regulatory proteins 1 and 2 bind distinct sets of RNA target sequences. J Biol Chem 1996; 271: 49008.DOI: 10.1074/jbc.271.9.4900
  • 55
    Casey JL, Hentze MW, Koeller DM, Caughman SW, Rouault TA, Klausner RD, Harford JB. Iron-responsive elements: regulatory RNA sequences that control mRNA levels and translation. Science 1988; 240: 9248.
  • 56
    Menotti E, Henderson BR, Kuhn LC. Translational regulation of mRNAs with distinct IRE sequences by iron regulatory proteins 1 and 2. J Biol Chem 1998; 273: 18214.DOI: 10.1074/jbc.273.3.1821
  • 57
    Erlitzki R, Long JC, Theil EC. Multiple, conserved iron-responsive elements in the 3′-untranslated region of transferrin receptor mRNA enhance binding of iron regulatory protein 2. J Biol Chem 2002; 277: 4257987.DOI: 10.1074/jbc.M207918200